GR3033677T3 - Valaciclovir tablets containing colloidal silicon dioxide - Google Patents

Valaciclovir tablets containing colloidal silicon dioxide

Info

Publication number
GR3033677T3
GR3033677T3 GR20000401364T GR20000401364T GR3033677T3 GR 3033677 T3 GR3033677 T3 GR 3033677T3 GR 20000401364 T GR20000401364 T GR 20000401364T GR 20000401364 T GR20000401364 T GR 20000401364T GR 3033677 T3 GR3033677 T3 GR 3033677T3
Authority
GR
Greece
Prior art keywords
silicon dioxide
colloidal silicon
tablets containing
containing colloidal
valaciclovir
Prior art date
Application number
GR20000401364T
Other languages
English (en)
Inventor
Barry Howard Carter
Lloyd Gary Tillman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3033677(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of GR3033677T3 publication Critical patent/GR3033677T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR20000401364T 1995-01-20 2000-06-14 Valaciclovir tablets containing colloidal silicon dioxide GR3033677T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet
PCT/GB1996/000111 WO1996022082A1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide

Publications (1)

Publication Number Publication Date
GR3033677T3 true GR3033677T3 (en) 2000-10-31

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401364T GR3033677T3 (en) 1995-01-20 2000-06-14 Valaciclovir tablets containing colloidal silicon dioxide

Country Status (39)

Country Link
US (1) US5879706A (el)
EP (1) EP0806943B1 (el)
JP (1) JP3350055B2 (el)
KR (1) KR100412298B1 (el)
CN (2) CN1131026C (el)
AP (1) AP666A (el)
AT (1) ATE190483T1 (el)
AU (1) AU710823B2 (el)
BG (1) BG63187B1 (el)
BR (1) BR9606769A (el)
CA (1) CA2210891C (el)
CY (1) CY2182B1 (el)
CZ (1) CZ296514B6 (el)
DE (1) DE69607146T2 (el)
DK (1) DK0806943T3 (el)
EA (1) EA000276B1 (el)
EE (1) EE03336B1 (el)
ES (1) ES2145425T3 (el)
FI (1) FI119722B (el)
GB (1) GB9501127D0 (el)
GE (1) GEP20022752B (el)
GR (1) GR3033677T3 (el)
HK (1) HK1002851A1 (el)
HU (1) HU226131B1 (el)
IL (1) IL116830A (el)
IN (1) IN181318B (el)
MY (1) MY126346A (el)
NO (1) NO311488B1 (el)
NZ (1) NZ298846A (el)
OA (1) OA10500A (el)
PL (1) PL185307B1 (el)
PT (1) PT806943E (el)
RO (1) RO118175B1 (el)
SK (1) SK282030B6 (el)
TR (1) TR199700657T1 (el)
UA (1) UA68325C2 (el)
UY (2) UY25774A1 (el)
WO (1) WO1996022082A1 (el)
ZA (1) ZA96448B (el)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DE69726255T2 (de) * 1996-01-19 2004-08-26 Glaxo Group Ltd., Greenford Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
SI20624A (sl) * 1998-12-18 2002-02-28 Abbott Laboratories Formulacija divalproeks natrija za kontrolirano sproščanje
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
PL366453A1 (en) * 2001-05-01 2005-02-07 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
US20040197396A1 (en) * 2001-11-05 2004-10-07 Fain Helen S Anhydrous crystal form of valaciclovir hydrochloride
PL371732A1 (en) * 2001-11-14 2005-06-27 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
AU2003240213A1 (en) * 2002-06-24 2004-01-06 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
WO2004035583A1 (en) * 2002-10-16 2004-04-29 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1633753A1 (en) * 2003-05-30 2006-03-15 EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. Novel crystalline forms of valacyclovir hydrochloride
EP1638972A2 (en) * 2003-06-02 2006-03-29 Teva Pharmaceutical Industries Limited Novel crystalline forms of valacyclovir hydrochloride
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
PL3395338T3 (pl) 2003-09-12 2019-10-31 Amgen Inc Szybko rozpuszczająca się formulacja zawierająca cynakalcet HCl
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1541133B1 (en) * 2003-12-09 2005-08-10 Helm AG Pharmaceutical formulation of valaciclovir
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
EP1868579B1 (en) 2005-03-07 2010-09-29 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
US7846937B2 (en) * 2005-05-25 2010-12-07 Eli Lilly And Company Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
JP2009536165A (ja) * 2006-05-10 2009-10-08 エボニック デグサ ゲーエムベーハー 医薬組成物におけるロール圧縮された熱分解的に製造された二酸化ケイ素の使用
KR20090018843A (ko) * 2006-05-31 2009-02-23 버텍스 파마슈티칼스 인코포레이티드 인터류킨-1 베타 전환효소 억제제의 경구용 조절 방출 제제
WO2008006534A2 (en) * 2006-07-11 2008-01-17 Lek Pharmaceuticals D.D. Multiple unit tablets
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
EP2407166B1 (en) * 2009-03-13 2013-08-21 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
CN116528853A (zh) * 2020-12-01 2023-08-01 株式会社Lg化学 包含1-(3-氰基-1-异丙基-吲哚-5-基)吡唑-4-甲酸的口服制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.
NL9220009A (nl) * 1991-01-30 1993-11-01 Wellcome Found In water-dispergeerbare tabletten.
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
CN1179100A (zh) 1998-04-15
PT806943E (pt) 2000-08-31
AP9701057A0 (en) 1997-10-31
CA2210891A1 (en) 1996-07-25
CN1131026C (zh) 2003-12-17
IN181318B (el) 1998-05-09
IL116830A (en) 2000-02-29
EE03336B1 (et) 2001-02-15
AP666A (en) 1998-08-24
RO118175B1 (ro) 2003-03-28
PL321361A1 (en) 1997-12-08
KR19980701524A (ko) 1998-05-15
FI973062A (fi) 1997-09-18
HU226131B1 (en) 2008-05-28
US5879706A (en) 1999-03-09
WO1996022082A1 (en) 1996-07-25
NO973327L (no) 1997-09-16
BG63187B1 (bg) 2001-06-29
EA199700123A1 (ru) 1997-12-30
ES2145425T3 (es) 2000-07-01
UY25774A1 (es) 2000-10-31
CN1313081C (zh) 2007-05-02
CY2182B1 (en) 2002-08-23
NO973327D0 (no) 1997-07-18
EA000276B1 (ru) 1999-02-25
OA10500A (en) 2002-04-10
CZ296514B6 (cs) 2006-03-15
JPH10512564A (ja) 1998-12-02
SK282030B6 (sk) 2001-10-08
FI973062A0 (fi) 1997-07-18
HUP9801872A3 (en) 2001-02-28
HK1002851A1 (en) 1998-09-25
ZA96448B (en) 1996-08-07
GEP20022752B (en) 2002-08-26
NZ298846A (en) 1998-06-26
KR100412298B1 (ko) 2004-04-21
CZ229297A3 (cs) 1998-02-18
PL185307B1 (pl) 2003-04-30
DE69607146D1 (de) 2000-04-20
SK96497A3 (en) 1998-01-14
MX9705459A (es) 1997-10-31
EP0806943B1 (en) 2000-03-15
CN1494898A (zh) 2004-05-12
AU4453496A (en) 1996-08-07
IL116830A0 (en) 1996-05-14
MY126346A (en) 2006-09-29
UY25778A1 (es) 2000-08-21
TR199700657T1 (xx) 1998-02-21
FI119722B (fi) 2009-02-27
UA68325C2 (en) 2004-08-16
BR9606769A (pt) 1997-12-30
GB9501127D0 (en) 1995-03-08
DK0806943T3 (da) 2000-07-24
EP0806943A1 (en) 1997-11-19
JP3350055B2 (ja) 2002-11-25
HUP9801872A2 (hu) 1999-10-28
CA2210891C (en) 2009-05-19
BG101831A (en) 1998-04-30
DE69607146T2 (de) 2000-09-21
NO311488B1 (no) 2001-12-03
AU710823B2 (en) 1999-09-30
ATE190483T1 (de) 2000-04-15

Similar Documents

Publication Publication Date Title
AP9701057A0 (en) Valaciclovir tablets containing colloidal silicon dioxide
IL110194A0 (en) Silicon device production
GB9308217D0 (en) Package dispenser
AU127356S (en) Bottle
AU126948S (en) Bottle
AU126887S (en) Bottle
AU127407S (en) Bottle
SI0806943T1 (en) Valaciclovir tablets containing colloidal silicon dioxide
AU127409S (en) Bottle
GB2297080B (en) Package
GB2285433B (en) Pill dispenser
AU126946S (en) Bottle
AU128063S (en) Bottle
AU126947S (en) Bottle
KR200165863Y1 (en) Wafer containing box
GB9505089D0 (en) Water-dispersible tablets containing acyclovir
CA71057S (en) Pill package
CA76599S (en) Package
CA76598S (en) Package
AU124644S (en) Small square container
IL107786A0 (en) Pill package
GB9512795D0 (en) Personal pill container
GB9521460D0 (en) Semiconductor devices
GB9501422D0 (en) Semiconductor devices
GB9508626D0 (en) Novelty beverage

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20110802